May 15 – 20, 2022
Casino Conference Centre
Europe/Prague timezone

Contribution List

234 / 234
Ms Hilde Lenaerts (University of Antwerp, Department of Chemistry, Laboratory of Adsorption and Catalysis (LADCA), Universiteitsplein 1, 2610 Wilrijk, Belgium; Flemish Institute for Technological Research (VITO NV), Boeretang 200, 2400 Mol, Belgium; Belgian Nuclear Research Centre (SCK CEN), Institute for Materials Science, Boeretang 200, 2400 Mol, Belgium)
5/19/22, 4:40 PM
Production and Application of Radionuclides

Cancer is a disease that still kills nearly 10 million people every year [1] despite the countless existing treatments. The amount of novel therapies is growing every day and targeted alpha therapy is one of them. Herein, the patient is treated with a radiopharmaceutical that binds to the cancer cell and emits ionizing radiation to induce cell damage. Since alpha radiation has a very short...

Paul Scully (National Nuclear Laboratory, UK)
5/19/22, 6:15 PM